New York State Common Retirement Fund
KYNB

New York State Common Retirement Fund’s Kyntra Bio KYNB Stock Holding History

New York State Common Retirement Fund’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$695 – 3240
2024
Q2 		$695 Sell
31
-1,394
-98% -$43.1K ﹤0.01% 3311
2024
Q1 		$83.7K Sell
1,425
-25
-2% -$1.08K ﹤0.01% 2815
2023
Q4 		$32.1K Sell
1,450
-10
-0.7% -$151 ﹤0.01% 3091
2023
Q3 		$31.5K Sell
1,460
-2,492
-63% -$97.9K ﹤0.01% 3125
2023
Q2 		$267K Sell
3,952
-1,069
-21% -$442K ﹤0.01% 2371
2023
Q1 		$2.34M Buy
5,021
+1,359
+37% +$719K ﹤0.01% 1476
2022
Q4 		$1.47M Buy
3,662
+384
+12% +$147K ﹤0.01% 1793
2022
Q3 		$1.07M Buy
3,278
+7
+0.2% +$2.25K ﹤0.01% 1938
2022
Q2 		$864K Sell
3,271
-6
-0.2% -$1.53K ﹤0.01% 2095
2022
Q1 		$985K Buy
3,277
+188
+6% +$65.5K ﹤0.01% 2117
2021
Q4 		$1.09M Sell
3,089
-8
-0.3% -$2.49K ﹤0.01% 2077
2021
Q3 		$791K Sell
3,097
-228
-7% -$80.8K ﹤0.01% 2224
2021
Q2 		$2.21M Sell
3,325
-5,208
-61% -$3M ﹤0.01% 1809
2021
Q1 		$7.41M Hold
8,533
– – 0.01% 1101
2020
Q4 		$7.91M Sell
8,533
-3,014
-26% -$3.17M 0.01% 1064
2020
Q3 		$11.9M Buy
11,547
+3,038
+36% +$3.27M 0.01% 777
2020
Q2 		$8.62M Buy
8,509
+168
+2% +$156K 0.01% 936
2020
Q1 		$7.25M Hold
8,341
– – 0.01% 913
2019
Q4 		$8.94M Sell
8,341
-416
-5% -$425K 0.01% 1001
2019
Q3 		$8.1M Buy
8,757
+100
+1% +$110K 0.01% 1030
2019
Q2 		$9.78M Buy
8,657
+2,058
+31% +$2.25M 0.01% 987
2019
Q1 		$8.97M Buy
6,599
+3,663
+125% +$4.97M 0.01% 996
2018
Q4 		$3.4M Sell
2,936
-456
-13% -$513K ﹤0.01% 1338
2018
Q3 		$5.15M Sell
3,392
-222
-6% -$342K 0.01% 1258
2018
Q2 		$5.66M Buy
3,614
+500
+16% +$652K 0.01% 1222
2018
Q1 		$3.6M Buy
3,114
+356
+13% +$469K ﹤0.01% 1346
2017
Q4 		$3.27M Sell
2,758
-106
-4% -$133K ﹤0.01% 1408
2017
Q3 		$3.85M Buy
2,864
+156
+6% +$164K ﹤0.01% 1326
2017
Q2 		$2.19M Buy
2,708
+524
+24% +$365K ﹤0.01% 1627
2017
Q1 		$1.35M Hold
2,184
– – ﹤0.01% 1885
2016
Q4 		$1.17M Hold
2,184
– – ﹤0.01% 1959
2016
Q3 		$1.13M Buy
2,184
+136
+7% +$64.1K ﹤0.01% 1941
2016
Q2 		$840K Buy
2,048
+88
+4% +$40.3K ﹤0.01% 2045
2016
Q1 		$1.04M Buy
1,960
+112
+6% +$55.8K ﹤0.01% 1919
2015
Q4 		$1.41M Hold
1,848
– – ﹤0.01% 1784
2015
Q3 		$1.01M Buy
1,848
+465
+34% +$282K ﹤0.01% 1940
2015
Q2 		$813K Buy
+1,383
New +$804K ﹤0.01% 2294

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

New York State Common Retirement Fund's KYNB Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 31 shares — an estimated $695 sold.

New York State Common Retirement Fund first reported a position in KYNB in Q2 2015 and held it in 37 quarters. The position peaked at $11.9M in Q3 2020. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 31 Kyntra Bio shares in Q3 2024, an estimated $695.
  • New York State Common Retirement Fund first reported a position in Kyntra Bio in Q2 2015 and held it in 37 quarters.
  • New York State Common Retirement Fund's Kyntra Bio position peaked at $11.9M in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.